In vivo model for chronic direct intratesticular drug administration

Area of Science:

• Reproductive Biology
• Pharmacology
• Surgical Techniques

Background:

• Chronic drug delivery to the testes is challenging.
• Understanding the effects of intratesticular luteinizing hormone (LH) is crucial for reproductive health.
• Developing targeted drug delivery systems for the testes is an area of active research.

Purpose of the Study:

• To assess the efficacy and toxicity of a novel chronic direct intratesticular drug infusion method.
• To evaluate the impact of luteinizing hormone (LH) delivered directly into the testis.
• To establish a rat model for studying targeted testicular drug administration.

Main Methods:

• Chronic direct intratesticular infusion of luteinizing hormone (LH) or buffer using miniosmotic pumps in Copenhagen rats for 14 days.
• Assessment of spermatogenesis and steroidogenesis through testis weight, homogenization-resistant spermatid count, and in vitro LH response.
• Histological examination of testicular tissue to identify inflammatory responses.
• Evaluation of steroidogenesis maintenance in pituitary-suppressed rats receiving intratesticular LH.

Main Results:

• Direct intratesticular infusion of buffer or LH showed no adverse effects on spermatogenesis or steroidogenesis.
• Localized inflammatory response observed around the infusion tubing was the only significant side effect.
• Intratesticular LH infusion maintained steroidogenesis in pituitary-suppressed rats.
• Testes receiving direct LH infusion produced significantly higher testosterone levels compared to contralateral and systemically treated testes.

Conclusions:

• The miniosmotic pump system enables chronic, high-concentration administration of LH directly to the testis.
• This method is effective and has minimal adverse effects, making it a potentially valuable tool for testicular drug delivery.
• The findings suggest broader applicability for delivering other agents intratesticularly via this technique.